Focusrite ends the year with revenue as forecast, continued profit growth in the second half and revenue in line with our expected slower second-half growth. Cash of £22.8m is 10% higher than we forecast and is now over half the balance sheet. US tariffs will likely apply to Focusrite’s business there and management has been considering its response, while risks associated to Brexit appear relatively minor to us. It seems the share price continues to discount a significant acquisition.
Written by
Focusrite |
Second-half trading as expected with higher cash |
Full-year pre-close statement |
Consumer electronics |
18 September 2018 |
Share price performance
Business description
Next events
Analysts
Focusrite is a research client of Edison Investment Research Limited |
|||||||||||||||||||||||||||||||||||||||||||||||
Focusrite ends the year with revenue as forecast, continued profit growth in the second half and revenue in line with our expected slower second-half growth. Cash of £22.8m is 10% higher than we forecast and is now over half the balance sheet. US tariffs will likely apply to Focusrite’s business there and management has been considering its response, while risks associated to Brexit appear relatively minor to us. It seems the share price continues to discount a significant acquisition.
Year end |
Revenue (£m) |
PBT* |
EPS* |
DPS |
P/E |
EV/EBITDA |
Yield |
08/16 |
54.3 |
7.7 |
11.8 |
2.0 |
37.9 |
24.8 |
0.4 |
08/17 |
66.1 |
9.5 |
14.8 |
2.7 |
30.2 |
18.7 |
0.6 |
08/18e |
75.4 |
10.8 |
16.3 |
3.0 |
27.4 |
16.2 |
0.7 |
08/19e |
80.0 |
11.5 |
17.0 |
3.3 |
26.3 |
15.7 |
0.7 |
Note: *PBT and EPS are normalised, excluding amortisation of acquired intangibles, exceptional items and share-based payments.
Revenue and trading in line, cash above forecast
Focusrite has indicated that H2 revenue, profits and cash have all continued in y-o-y growth in H2, consistent with our profit and loss forecast. Growth has been broadly based across core product areas and in all major regions. In addition, positive results reported from expansion into new markets indicate a return on recent investment in Asia and potentially Latin America.
Cash: Further strengthens balance sheet
Net cash of £22.8m at August is 10% above our forecast and a net £8.6m rise in the year. As profits are in line, the beat was effectively achieved by continued control over working capital. The added cash may heighten observers’ expectations of an acquisition, but the company continues the same stringent screening process.
Macro risks flagged: US and Europe
With some 40% of Focusrite’s sales in the US and production in China, the company expects that extended tariffs will be applied to its products in common with its competitors. Management has been planning for this and considering the natural choice between absorbing the impact or passing it on to customers. Depending on Brexit outcomes, sterling could strengthen if a deal is struck, which, subject to the company’s hedging arrangements would affect the sterling value of the company’s euro sales. In another scenario, customs hold-ups might affect distribution of Focusrite’s product, although this should be manageable.
Valuation: No change in our view
On a DCF basis, the share price remains equivalent to a medium-term organic growth rate of about 12%. On a peer group comparison, the picture is mixed: the shares trade at a 2% P/E discount for FY18e but a 30% premium for FY19e. On an EV/EBITDA basis the company trades at a premium of 21% for FY18e and 32% for FY19e. The missing element is the excess cash, where the market appears to be discounting investment of the net cash balance at a c 15% post-tax return.
Full year pre-close
Revenue and profit: H2 at least equal to our forecast
Focusrite has indicated that H2 revenue, profits and cash have all continued in y-o-y growth. That is consistent with our profit and loss forecast and better than our previously forecast year-end cash of £20.8m.
Exhibit 1: H1/H2 forecast
£000s |
H117 |
H217 |
FY17 |
H118 |
H218e |
FY18e |
H1 y-o-y |
H2 y-o-y |
FY y-o-y |
Revenue |
32,020 |
34,035 |
66,055 |
38,819 |
36,593 |
75,412 |
21.2% |
7.5% |
14.2% |
Gross profit |
12,855 |
13,496 |
26,351 |
16,200 |
15,282 |
31,482 |
26.0% |
13.2% |
19.5% |
Gross margin |
40.1% |
39.7% |
39.9% |
41.7% |
41.8% |
41.7% |
3.9% |
5.3% |
4.6% |
Adjusted EBITDA |
6,131 |
6,978 |
13,109 |
7,969 |
7,159 |
15,128 |
30.0% |
2.6% |
15.4% |
Adjusted EBITDA margin |
19.1% |
20.5% |
19.8% |
20.5% |
19.6% |
20.1% |
7.2% |
-4.6% |
1.1% |
Operating profit |
4,571 |
4,899 |
9,470 |
6,230 |
4,994 |
11,224 |
36.3% |
1.9% |
18.5% |
Pre-tax profit |
4,599 |
4,913 |
9,512 |
5,833 |
5,004 |
10,837 |
26.8% |
1.8% |
13.9% |
EPS (p) |
7.0 |
7.8 |
14.8 |
16.3 |
17.0 |
17.6 |
133.2% |
117.5% |
18.8% |
Net cash |
9,391 |
14,174 |
14,174 |
19,734 |
22,881 |
22,881 |
110.1% |
61.4% |
61.4% |
Source: Focusrite, Edison Investment Research
Focusrite confirms revenue for the year is c £75m, in line with our expectation of £75.4m. This implies second half sterling-reported growth of 7.5% compared with 21% in H1 to give 14% for the full year. On a constant currency basis, full-year revenue growth of over 15% compared with 26% in H1 implies H2 growth of 4–5%. That is a good level of increase, especially as management indicates it was broadly based across core product areas and in all major regions. In addition, positive results reported from expansion into new markets indicates a return on the recent investment made into the sales regions of Asia and, to a lesser extent, Latin America.
The company does not quantify the level of H2 profit growth, but our pre-tax forecast of 1.8% was deliberately cautious so there could be a further step up to the actual result when reported in November 2018.
The statement also refers to moves, set out at the full year, to structure sales programmes to enhance the lifetime value of customers, which should bring benefits over the medium term.
Cash: Adding further strength to the balance sheet
Focusrite has increased net cash to £22.8m, an £8.6m rise in the year. That is 10% higher than our previous forecast of £20.8m. This was achieved mainly by the value added by increased profits, as well as prudent working capital management. We understand that there is unlikely to be a material reversal of the working capital position post year end. As a result, the balance sheet is even stronger than we previously recognised, with 56% of shareholders’ equity in cash.
Potential acquisition activity
Management has made no secret of the fact that it considers acquisitions as a growth vehicle, and we understand that the process of reviewing possible acquisitions remains active. Some candidates offer themselves because the company has excess cash and has expressed an inclination to seek acquisition assets. Others are identified by management as part of a screening process for likely targets that meet its strategic criteria.
Macro factors present potential risk
Management references macroeconomic risks in its statement. These are in two separate areas, the US and Europe:
Macro factors: US
Focusrite’s products are sourced from China and c 41% of its sales are into the US. Management expects these to become subject to the latest round of tariffs imposed on imports into the US from China. News reports have suggested an initial 10% level for the tariffs. As the breadth of applicable products has widened, Focusrite has been planning for this and considering the natural choice between absorbing the impact or passing it on to customers. Its competitors in both its main product areas will need to make the same choice.
That said, it is becoming clear that Trump’s negotiating style is to create a major threat as a show of power, leading to a strong base that can then be used to make discussions more productive. If this represents such a tactic and it works as intended, the risk could be reduced.
Macro factors: Europe
The major risk factor in Europe is clearly Brexit. It is therefore uncertain precisely how such risks could play out in practice, but the main areas we would focus on are:
■
Exchange rate fluctuations: markets to some extent reflect a no-deal scenario and sterling could strengthen if a deal is struck. If this happened, it could impact sterling value of the company’s euro sales (c 25% of revenue). We understand the company has hedged c 70% of its FY19 and c 25% of its FY20 exposure.
■
Product distribution: the principal risk is that customs hold-ups following some versions of a Brexit deal, or no deal, might affect distribution of Focusrite’s product. On the plus side, the company sends its product to distributors, who supply end retailers, so that fine timing is not a major issue. Also, Focusrite uses internationally established freight forwarders who are likely to have the best systems and strategies for avoiding unnecessary delays.
Forecast: No change to profit or earnings
We make no changes to our forecast profit and loss for FY18 or FY19. We reflect year-end net cash of £22.8m as confirmed in the statement. Looking forward, we cautiously assume that £1m of the £2m uplift in that figure rolls forward to FY19.
Valuation: No change in our view
With no change in our earnings forecast, we make no major alterations to our valuation metrics. We value the shares using DCF techniques to evaluate the longer-term income stream available to investors. As a secondary metric, we consider valuation in relation to a peer group of smaller companies on near-term earnings expectations, although few of these are close peers. However, as discussed below, neither metric fully reflects the potential of the company’s cash of £22.8m.
DCF valuation: Market is discounting substantial growth
Our DCF projection extends our forecasts out to 10 years with revenue growth fading in the last three years to a terminal rate of 2%. We assume a terminal EBITDA margin of 21% (as 19.8% was already achieved in 2017, this may be conservative) and capex investment at 7% of revenue, reducing to 5% in the terminal period. We assume an equity-only cost of capital of 8.4%.
It remains the case that the current share price is equivalent to a medium-term revenue growth rate of about 12%, well within previously achieved growth rates. Exhibit 2 below shows the share price implication of alternative sales growth rates, as well as terminal margin assumptions.
Exhibit 2: Sensitivity to medium-term growth rate and terminal margin
Sales growth FY21-25 |
||||||
8% |
10% |
12% |
14% |
16% |
||
Terminal margin |
23.0% |
428 |
461 |
497 |
536 |
577 |
22.0% |
408 |
439 |
473 |
509 |
548 |
|
21.0% |
387 |
417 |
449 |
483 |
520 |
|
20.0% |
367 |
395 |
425 |
457 |
491 |
|
19.0% |
347 |
373 |
401 |
431 |
463 |
|
Source: Edison Investment Research
Peer group reference: Mixed picture
Focusrite does not have a direct peer, but we compare it with UK smaller-cap tech, electronics and consumer companies in relevant subsectors, as well as relevant companies in US and European markets. This is far from an exact comparison but does give some context in terms of market valuations in adjacent sectors.
Exhibit 3: Peer valuations
P/E (x) |
EV/EBITDA (x) |
EV/Sales (x) |
||||
Yr1e |
Yr2e |
Yr1e |
Yr2e |
Yr1e |
Yr2e |
|
Universal Electronics |
19.5 |
12.8 |
9.3 |
7.1 |
0.6 |
|
Tivo |
11.7 |
11.8 |
10.4 |
3.3 |
3.3 |
|
Morgan Advanced Materials |
11.2 |
12.2 |
6.9 |
7.2 |
1.4 |
1.3 |
Photo-Me International |
13.6 |
13.1 |
6.4 |
6.2 |
2.4 |
2.3 |
Oxford Instruments |
17.3 |
15.9 |
10.8 |
10.2 |
2.8 |
2.8 |
Bang & Olufsen |
62.8 |
23.1 |
12.2 |
9.8 |
0.4 |
0.4 |
XP Power |
18.4 |
15.4 |
13.7 |
11.7 |
3.5 |
3.4 |
Avid Technology |
29.9 |
10.7 |
8.8 |
0.5 |
||
Gooch & Housego |
30.1 |
26.1 |
17.8 |
15.6 |
4.0 |
3.8 |
Dialight |
24.3 |
13.6 |
11.2 |
7.4 |
1.1 |
1.0 |
Quixant |
27.1 |
24.5 |
19.7 |
17.8 |
3.2 |
2.8 |
Judges Scientific |
22.0 |
18.7 |
13.4 |
13.3 |
2.7 |
2.6 |
B&C Speakers |
16.9 |
12.2 |
2.7 |
2.5 |
||
Trakm8 Holdings |
8.2 |
5.1 |
0.9 |
|||
Gear4music Holdings |
61.9 |
42.2 |
28.3 |
20.8 |
1.9 |
1.4 |
Average |
27.6 |
20.0 |
13.2 |
11.7 |
2.4 |
2.6 |
Focusrite |
27.0 |
25.9 |
16.0 |
15.4 |
3.2 |
3.0 |
Premium/(discount) |
-2.3% |
29.6% |
21.2% |
32.1% |
35.5% |
17.2% |
Source: Bloomberg. Note: Based on market prices at 17 September 2018.
Focusrite trades on a 2% P/E discount for FY18e but a 30% premium for FY19e. On an EV/EBITDA basis, it trades at a premium of 21% for FY18e and 32% for FY19e. On an EV/sales basis the company also trades at a premium to the peer group.
The cash valuation gap got bigger
While on the face of it our metrics do not point to valuation at or above current market levels, what is left out of the equation is how Focusrite’s increased excess cash of £22.8m may be used. Here we consider the likely effect of using it to make an accretive acquisition.
As we analysed in our April note, Focusrite generates high average taxed ROCE rates of 45–51%. It is not likely that the company could generate such returns from an acquisition. However, using a range of lower ROCE rates, the cash would imply additional value as follows:
Exhibit 4: Potential value impact of excess cash (£m/p per share)
ROCE |
10% |
15% |
20% |
Excess cash |
22.8 |
22.8 |
22.8 |
Post-tax earnings |
2.3 |
3.4 |
4.6 |
Incremental EPS |
3.9 |
5.9 |
7.8 |
Pro forma FY19 EPS |
20.9 |
22.8 |
24.8 |
Peer P/E |
20 |
20 |
20 |
Implied share valuation (p) |
417 |
456 |
495 |
Source: Edison Investment Research
Hence, it would seem the market appears to be discounting investment of the net cash balance at a c 15% post-tax return.
Exhibit 5: Financial summary
£000s |
2016 |
2017 |
2018e |
2019e |
2020e |
||
31-August |
IFRS |
IFRS |
IFRS |
IFRS |
IFRS |
||
INCOME STATEMENT |
|||||||
Revenue |
|
|
54,301 |
66,055 |
75,412 |
80,022 |
86,023 |
Cost of Sales |
(33,439) |
(39,704) |
(43,930) |
(46,615) |
(50,111) |
||
Gross Profit |
20,862 |
26,351 |
31,482 |
33,406 |
35,912 |
||
EBITDA |
|
|
10,249 |
13,109 |
15,128 |
15,662 |
16,660 |
Operating profit (before amort. and except). |
|
7,677 |
9,470 |
11,224 |
11,465 |
12,183 |
|
Amortisation of acquired intangibles |
0 |
0 |
0 |
0 |
0 |
||
Exceptionals |
(537) |
0 |
0 |
0 |
0 |
||
Share-based payments |
0 |
0 |
0 |
0 |
0 |
||
Reported operating profit |
7,140 |
9,470 |
11,224 |
11,465 |
12,183 |
||
Net Interest |
(14) |
42 |
(387) |
50 |
50 |
||
Joint ventures & associates (post tax) |
0 |
0 |
0 |
0 |
0 |
||
Exceptionals |
0 |
0 |
0 |
0 |
0 |
||
Profit Before Tax (norm) |
|
|
7,663 |
9,512 |
10,837 |
11,515 |
12,233 |
Profit Before Tax (reported) |
|
|
7,126 |
9,512 |
10,837 |
11,515 |
12,233 |
Reported tax |
(870) |
(959) |
(1,300) |
(1,555) |
(1,835) |
||
Profit After Tax (norm) |
6,793 |
8,553 |
9,536 |
9,961 |
10,398 |
||
Profit After Tax (reported) |
6,256 |
8,553 |
9,536 |
9,961 |
10,398 |
||
Minority interests |
0 |
0 |
0 |
0 |
0 |
||
Discontinued operations |
0 |
0 |
0 |
0 |
0 |
||
Net income (normalised) |
6,900 |
8,553 |
9,536 |
9,961 |
10,398 |
||
Net income (reported) |
6,256 |
8,553 |
9,536 |
9,961 |
10,398 |
||
Basic average number of shares outstanding (m) |
53.2 |
55.4 |
56.7 |
56.7 |
56.7 |
||
EPS - basic normalised (p) |
|
|
13.0 |
15.4 |
16.8 |
17.6 |
18.3 |
EPS - normalised (p) |
|
|
11.8 |
14.8 |
16.3 |
17.0 |
17.6 |
EPS - basic reported (p) |
|
|
11.8 |
15.4 |
16.8 |
17.6 |
18.3 |
Dividend per share (p) |
2.0 |
2.7 |
3.0 |
3.3 |
3.7 |
||
Revenue growth (%) |
13.1 |
21.6 |
14.2 |
6.1 |
7.5 |
||
Gross Margin (%) |
38.4 |
39.9 |
41.7 |
41.7 |
41.7 |
||
EBITDA Margin (%) |
18.9 |
19.8 |
20.1 |
19.6 |
19.4 |
||
Normalised Operating Margin |
14.1 |
14.3 |
14.9 |
14.3 |
14.2 |
||
BALANCE SHEET |
13,748 |
11,520 |
14,625 |
17,321 |
|||
Fixed Assets |
|
|
6,367 |
6,332 |
6,940 |
8,138 |
9,462 |
Intangible Assets |
4,792 |
4,963 |
5,737 |
7,107 |
8,579 |
||
Tangible Assets |
1,575 |
1,369 |
1,203 |
1,031 |
883 |
||
Investments & other |
0 |
0 |
0 |
0 |
0 |
||
Current Assets |
|
|
28,191 |
36,126 |
44,080 |
51,129 |
58,282 |
Stocks |
11,361 |
9,000 |
9,629 |
11,047 |
12,494 |
||
Debtors |
11,224 |
12,952 |
11,570 |
13,593 |
15,319 |
||
Cash & cash equivalents |
5,606 |
14,174 |
22,881 |
26,489 |
30,470 |
||
Other |
0 |
0 |
0 |
0 |
0 |
||
Current Liabilities |
|
|
(9,256) |
(8,663) |
(9,936) |
(10,322) |
(10,854) |
Creditors |
(8,612) |
(8,204) |
(9,679) |
(10,015) |
(10,492) |
||
Tax and social security |
(644) |
(459) |
(257) |
(307) |
(363) |
||
Short term borrowings |
0 |
0 |
0 |
0 |
0 |
||
Other |
0 |
0 |
0 |
0 |
0 |
||
Long Term Liabilities |
|
|
(282) |
(245) |
(287) |
(361) |
(440) |
Long term borrowings |
0 |
0 |
0 |
0 |
0 |
||
Other long term liabilities |
(282) |
(245) |
(287) |
(361) |
(440) |
||
Net Assets |
|
|
25,020 |
33,550 |
40,797 |
48,585 |
56,449 |
Minority interests |
0 |
0 |
0 |
0 |
0 |
||
Shareholders' equity |
|
|
25,020 |
33,550 |
40,797 |
48,585 |
56,449 |
CASH FLOW |
|||||||
Op Cash Flow before WC and tax |
10,249 |
13,109 |
15,128 |
15,662 |
16,660 |
||
Working capital |
(6,009) |
407 |
1,562 |
(3,105) |
(2,696) |
||
Exceptional & other |
(417) |
137 |
(0) |
(0) |
(0) |
||
Tax |
(165) |
(633) |
(1,300) |
(1,555) |
(1,835) |
||
Net operating cash flow |
|
|
3,658 |
13,020 |
15,390 |
11,003 |
12,128 |
Capex |
(3,675) |
(3,614) |
(4,594) |
(5,557) |
(6,095) |
||
Acquisitions/disposals |
0 |
0 |
0 |
0 |
0 |
||
Net interest |
(111) |
(42) |
(387) |
50 |
50 |
||
Equity financing |
172 |
258 |
0 |
0 |
0 |
||
Dividends |
(976) |
(1,138) |
(1,702) |
(1,888) |
(2,103) |
||
Other |
365 |
84 |
0 |
0 |
0 |
||
Net Cash Flow |
(567) |
8,568 |
8,707 |
3,608 |
3,980 |
||
Opening net debt/(cash) |
|
|
(6,173) |
(5,606) |
(14,174) |
(22,881) |
(26,489) |
FX |
0 |
0 |
0 |
0 |
0 |
||
Other non-cash movements |
0 |
0 |
0 |
0 |
0 |
||
Closing net debt/(cash) |
|
|
(5,606) |
(14,174) |
(22,881) |
(26,489) |
(30,470) |
Source: Focusrite, Edison Investment Research
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting. Edison is authorised and regulated by the Financial Conduct Authority. Edison Investment Research (NZ) Limited (Edison NZ) is the New Zealand subsidiary of Edison. Edison NZ is registered on the New Zealand Financial Service Providers Register (FSP number 247505) and is registered to provide wholesale and/or generic financial adviser services only. Edison Investment Research Inc (Edison US) is the US subsidiary of Edison and is regulated by the Securities and Exchange Commission. Edison Investment Research Limited (Edison Aus) [46085869] is the Australian subsidiary of Edison. Edison Germany is a branch entity of Edison Investment Research Limited [4794244]. www.edisongroup.com DISCLAIMER |
Frankfurt +49 (0)69 78 8076 960 Schumannstrasse 34b 60325 Frankfurt Germany |
London +44 (0)20 3077 5700 280 High Holborn London, WC1V 7EE United Kingdom |
New York +1 646 653 7026 295 Madison Avenue, 18th Floor 10017, New York US |
Sydney +61 (0)2 8249 8342 Level 4, Office 1205 95 Pitt Street, Sydney NSW 2000, Australia |
Frankfurt +49 (0)69 78 8076 960 Schumannstrasse 34b 60325 Frankfurt Germany |
London +44 (0)20 3077 5700 280 High Holborn London, WC1V 7EE United Kingdom |
New York +1 646 653 7026 295 Madison Avenue, 18th Floor 10017, New York US |
Sydney +61 (0)2 8249 8342 Level 4, Office 1205 95 Pitt Street, Sydney NSW 2000, Australia |
Research: Investment Companies
Invesco Asia Trust (IAT) aims to deliver significant capital gains to shareholders over a three- to five-year horizon, primarily through investing in Asian equities, following a disciplined, bottom-up process. It has a solid long-term track record of NAV total return outperformance against its benchmark and has delivered annualised returns of 13% pa over the past 10 years. Although the primary objective is capital gains, since 2001 IAT has also consistently maintained or grown dividends, which increased 28% in FY18. The MSCI Asia ex-Japan index has corrected nearly 20% from its January 2018 peak and the manager believes many interesting investment ideas are emerging.